Purpose. The efficacy, safety, pharmacology, pharmacokinetics, drug–drug interactions, and administration of alvimopan for postoperative ileus are reviewed. Summary. Alvimopan is a selective µ-opioid ...
Purpose. Characteristics of the ideal drug therapy for postoperative ileus (POI); the pharmacology, efficacy, and safety of currently available nonselective opioid antagonists and the new peripherally ...
HERPEN, Netherlands, Oct. 9, 2025 /PRNewswire/ -- Orexa B.V., a Dutch life sciences company focused on improving recovery and nutritional status in patients, today announced positive interim results ...
Postoperative ileus is a common complication and can be associated with prolonged hospital stay. Alvimopan, a µ-opioid receptor antagonist, has been shown to reduce the duration of postoperative ileus ...
COLLEGEVILLE, Pa. & TARRYTOWN, N.Y., Mar 12, 2008 (BUSINESS WIRE) -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced ...
DelveInsight's Postoperative Ileus Market Insights report includes a comprehensive understanding of current treatment practices, postoperative ileus emerging drugs, market share of individual ...
Former Argentine President Cristina Fernández de Kirchner remains hospitalized at the Otamendi Sanatorium in Buenos Aires after developing postoperative ileus, a functional intestinal complication ...
Considering taking supplements to treat Postoperative ileus? Below is a list of common natural remedies used to treat or reduce the symptoms of Postoperative ileus. Follow the links to read common ...
The postoperative ileus market is expected to witness steady growth driven by the rising volume of abdominal and gastrointestinal surgeries worldwide. Increasing awareness of enhanced recovery ...
The postoperative ileus market is expected to witness steady growth driven by the rising volume of abdominal and gastrointestinal surgeries worldwide. Increasing awareness of enhanced recovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results